Blog
RSS FeedPosted by Michael Wonder on 24 Dec 2023
AstraZeneca cancer drug Calquence cost tumbles with PBS listing
23 December 2023 - An AstraZeneca drug’s listing on the PBS from January 1 will see bills fall massively for people ...
Posted by Michael Wonder on 02 Dec 2023
Keytruda is a step closer to being available for more cancers listed on the PBS
1 December 2023 - Thousands of cancer patients in Australia will benefit from a major change that would see Keytruda offered ...
Posted by Michael Wonder on 16 Nov 2023
New treatment for advanced prostate cancer added to the PBS
16 November 2023 - Prostate cancer is one of the most commonly diagnosed cancer in Australia. ...
Posted by Michael Wonder on 06 Nov 2023
New treatment for women battling aggressive breast cancer
6 November 2023 - Women diagnosed with an aggressive form of breast cancer will have access to new treatment through the ...
Posted by Michael Wonder on 06 Nov 2023
New drug on PBS offers hope for women with aggressive breast cancer
5 November 2023 - A cutting-edge breast cancer drug has been added to the PBS for women with an especially ...
Posted by Michael Wonder on 02 Nov 2023
Launch of the Australian Cancer Plan
2 November 2023 - Learn about the new Australian Cancer Plan, which aims to improve prevention, screening, treatment and management of ...
Posted by Michael Wonder on 27 Sep 2023
Expanded medicines for breast cancer and leukaemia on the PBS
26 September 2023 - From 1 September 2023, Australians with an aggressive form of breast cancer and certain types of leukaemia ...
Posted by Michael Wonder on 08 Sep 2023
Review of cancer related surrogate outcomes used for PBAC decision-making
8 September 2023 - Surrogate outcome measures have an increasingly important role in cancer medicine research providing evidence to support ...
Posted by Michael Wonder on 28 Aug 2023
Efficient Funding of Chemotherapy Review – final report
28 August 2023 - The final report of the Efficient Funding of Chemotherapy Review is now available. ...
Posted by Michael Wonder on 18 Aug 2023
Estimating overall survival in people receiving PBS listed cancer medicines in Australian clinical practice
18 August 2023 - In September 2021, the Department of Health and Aged Care contracted the Medicines Intelligence Centre for ...
Posted by Michael Wonder on 15 Aug 2023
New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS
14 August 2023 - From August 2023, Australians with chronic migraine and soft tissue sarcoma will have access to new ...
Posted by Michael Wonder on 01 Aug 2023
Global sarcoma therapy now listed on Pharmaceutical Benefits Scheme
31 July 2023 - Yondelis (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine. ...
Posted by Michael Wonder on 31 Jul 2023
Schedule of Pharmaceutical Benefits - 1 August 2023
1 August 2023 - The August 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 28 Jun 2023
Breast cancer survivor wants $7,000 a month wonder drug to be more readily available to patients
23 June 2023 - A young Wollongong mother has spoken about her "remarkable" recovery from a breast cancer that had ...
Posted by Michael Wonder on 05 Jun 2023
New treatments for Australians with endometrial cancer and Lennox-Gastaut syndrome
5 June 2023 - From 1 June 2023, Australians with endometrial cancer and Lennox-Gastaut syndrome will have access to new ...